| Jennifer Winthrop Golkowski, NP | |
|
3073 White Mountain Hwy, North Conway, NH 03860-7101 | |
| (603) 356-0796 | |
| Not Available |
| Full Name | Jennifer Winthrop Golkowski |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 3073 White Mountain Hwy, North Conway, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043680853 | NPI | - | NPPES |
| 5103273 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | CNP191194 (Maine) | Secondary |
| 363LA2100X | Nurse Practitioner - Acute Care | 072788-23 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital, The | North conway, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Memorial Hospital | 2365418993 | 86 |
News Archive
Participating in his first full length radio interview since his famously shouted "You Lie" remark during President Obama's address to Congress propelled him into the media spotlight, Congressman Joe Wilson (R-SC) appeared on the nationally syndicated Neal Asbury Show on WZAB-AM. Congressman Wilson attributed his dramatic vocal response to a "town hall moment," a visceral reaction to what he inherently knew was Obama's misrepresentation of the citizenship immigration policy.
The DECIDE study shows that 4-weekly daclizumab high-yield process reduces disease activity in patients with relapsing–remitting multiple sclerosis more effectively than weekly interferon beta-1a, albeit at the cost of more adverse effects.
Novartis Pharmaceuticals Corporation announced today that results of a Phase III study show Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival, or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET). The study, RADIANT-3, was presented at the 12th World Congress on Gastrointestinal Cancer and is part of the largest clinical trial program in patients with advanced NET.
"A new report from the Results for Development Institute," released to coincide with World Malaria Day on Wednesday, "suggests there are ways to save and reinvest badly needed funds, by getting better value for money out of the bednets distributed in endemic areas," Guardian Health Editor Sarah Boseley reports in her "Global Health Blog."
In one of the largest prevalence studies to date, researchers from the U.K. provide national, regional, and global genotype prevalence estimates for the hepatitis C virus (HCV). Findings published in Hepatology, a journal of the American Association for the Study of Liver Diseases, indicate that genotype 1 is the most prevalent worldwide, with over 83 million patients infected of which one-third reside in East Asia.
› Verified 6 days ago
| Entity Name | Maine Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447354899 PECOS PAC ID: 9335043967 Enrollment ID: O20040330000128 |
News Archive
Participating in his first full length radio interview since his famously shouted "You Lie" remark during President Obama's address to Congress propelled him into the media spotlight, Congressman Joe Wilson (R-SC) appeared on the nationally syndicated Neal Asbury Show on WZAB-AM. Congressman Wilson attributed his dramatic vocal response to a "town hall moment," a visceral reaction to what he inherently knew was Obama's misrepresentation of the citizenship immigration policy.
The DECIDE study shows that 4-weekly daclizumab high-yield process reduces disease activity in patients with relapsing–remitting multiple sclerosis more effectively than weekly interferon beta-1a, albeit at the cost of more adverse effects.
Novartis Pharmaceuticals Corporation announced today that results of a Phase III study show Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival, or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET). The study, RADIANT-3, was presented at the 12th World Congress on Gastrointestinal Cancer and is part of the largest clinical trial program in patients with advanced NET.
"A new report from the Results for Development Institute," released to coincide with World Malaria Day on Wednesday, "suggests there are ways to save and reinvest badly needed funds, by getting better value for money out of the bednets distributed in endemic areas," Guardian Health Editor Sarah Boseley reports in her "Global Health Blog."
In one of the largest prevalence studies to date, researchers from the U.K. provide national, regional, and global genotype prevalence estimates for the hepatitis C virus (HCV). Findings published in Hepatology, a journal of the American Association for the Study of Liver Diseases, indicate that genotype 1 is the most prevalent worldwide, with over 83 million patients infected of which one-third reside in East Asia.
› Verified 6 days ago
| Entity Name | Maine Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104921535 PECOS PAC ID: 9335043967 Enrollment ID: O20040331000274 |
News Archive
Participating in his first full length radio interview since his famously shouted "You Lie" remark during President Obama's address to Congress propelled him into the media spotlight, Congressman Joe Wilson (R-SC) appeared on the nationally syndicated Neal Asbury Show on WZAB-AM. Congressman Wilson attributed his dramatic vocal response to a "town hall moment," a visceral reaction to what he inherently knew was Obama's misrepresentation of the citizenship immigration policy.
The DECIDE study shows that 4-weekly daclizumab high-yield process reduces disease activity in patients with relapsing–remitting multiple sclerosis more effectively than weekly interferon beta-1a, albeit at the cost of more adverse effects.
Novartis Pharmaceuticals Corporation announced today that results of a Phase III study show Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival, or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET). The study, RADIANT-3, was presented at the 12th World Congress on Gastrointestinal Cancer and is part of the largest clinical trial program in patients with advanced NET.
"A new report from the Results for Development Institute," released to coincide with World Malaria Day on Wednesday, "suggests there are ways to save and reinvest badly needed funds, by getting better value for money out of the bednets distributed in endemic areas," Guardian Health Editor Sarah Boseley reports in her "Global Health Blog."
In one of the largest prevalence studies to date, researchers from the U.K. provide national, regional, and global genotype prevalence estimates for the hepatitis C virus (HCV). Findings published in Hepatology, a journal of the American Association for the Study of Liver Diseases, indicate that genotype 1 is the most prevalent worldwide, with over 83 million patients infected of which one-third reside in East Asia.
› Verified 6 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Participating in his first full length radio interview since his famously shouted "You Lie" remark during President Obama's address to Congress propelled him into the media spotlight, Congressman Joe Wilson (R-SC) appeared on the nationally syndicated Neal Asbury Show on WZAB-AM. Congressman Wilson attributed his dramatic vocal response to a "town hall moment," a visceral reaction to what he inherently knew was Obama's misrepresentation of the citizenship immigration policy.
The DECIDE study shows that 4-weekly daclizumab high-yield process reduces disease activity in patients with relapsing–remitting multiple sclerosis more effectively than weekly interferon beta-1a, albeit at the cost of more adverse effects.
Novartis Pharmaceuticals Corporation announced today that results of a Phase III study show Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival, or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET). The study, RADIANT-3, was presented at the 12th World Congress on Gastrointestinal Cancer and is part of the largest clinical trial program in patients with advanced NET.
"A new report from the Results for Development Institute," released to coincide with World Malaria Day on Wednesday, "suggests there are ways to save and reinvest badly needed funds, by getting better value for money out of the bednets distributed in endemic areas," Guardian Health Editor Sarah Boseley reports in her "Global Health Blog."
In one of the largest prevalence studies to date, researchers from the U.K. provide national, regional, and global genotype prevalence estimates for the hepatitis C virus (HCV). Findings published in Hepatology, a journal of the American Association for the Study of Liver Diseases, indicate that genotype 1 is the most prevalent worldwide, with over 83 million patients infected of which one-third reside in East Asia.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Winthrop Golkowski, NP 3073 White Mountain Hwy, North Conway, NH 03860-7101 Ph: (603) 356-0796 | Jennifer Winthrop Golkowski, NP 3073 White Mountain Hwy, North Conway, NH 03860-7101 Ph: (603) 356-0796 |
News Archive
Participating in his first full length radio interview since his famously shouted "You Lie" remark during President Obama's address to Congress propelled him into the media spotlight, Congressman Joe Wilson (R-SC) appeared on the nationally syndicated Neal Asbury Show on WZAB-AM. Congressman Wilson attributed his dramatic vocal response to a "town hall moment," a visceral reaction to what he inherently knew was Obama's misrepresentation of the citizenship immigration policy.
The DECIDE study shows that 4-weekly daclizumab high-yield process reduces disease activity in patients with relapsing–remitting multiple sclerosis more effectively than weekly interferon beta-1a, albeit at the cost of more adverse effects.
Novartis Pharmaceuticals Corporation announced today that results of a Phase III study show Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival, or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET). The study, RADIANT-3, was presented at the 12th World Congress on Gastrointestinal Cancer and is part of the largest clinical trial program in patients with advanced NET.
"A new report from the Results for Development Institute," released to coincide with World Malaria Day on Wednesday, "suggests there are ways to save and reinvest badly needed funds, by getting better value for money out of the bednets distributed in endemic areas," Guardian Health Editor Sarah Boseley reports in her "Global Health Blog."
In one of the largest prevalence studies to date, researchers from the U.K. provide national, regional, and global genotype prevalence estimates for the hepatitis C virus (HCV). Findings published in Hepatology, a journal of the American Association for the Study of Liver Diseases, indicate that genotype 1 is the most prevalent worldwide, with over 83 million patients infected of which one-third reside in East Asia.
› Verified 6 days ago
Kimberly S. Macdermott, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3073 White Mountain Hwy, North Conway, NH 03860 Phone: 603-356-5472 Fax: 603-356-9647 | |
Linda J Barton, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3073 White Mountain Hwy, North Conway, NH 03860 Phone: 603-356-5461 | |
Mrs. Kathleen Blake Maynard, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3073 White Mountain Hwy, Primary Care, Memorial Hospital, North Conway, NH 03860 Phone: 603-356-5461 | |
Zachary Stephen Sevigny, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3073 White Mountain Hwy, North Conway, NH 03860 Phone: 603-356-5461 | |
Charisse N. Hirschfeld, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3073 White Mountain Hwy, North Conway, NH 03860 Phone: 603-356-5472 | |
Justine Fierman, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3073 White Mountain Hwy, Memorial Hospital, North Conway, NH 03860 Phone: 603-356-4949 |